Cargando…
Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured
BACKGROUND: Biomarkers can be subtle tools to aid the diagnosis, prognosis and monitoring of therapy and disease progression. The validation of biomarkers is a cumbersome process involving many steps. Serum samples from lung cancer patients were collected in the framework of a larger study for evalu...
Autores principales: | Kahn, Nicolas, Riedlinger, Julia, Roeßler, Markus, Rabe, Christina, Lindner, Michael, Koch, Ina, Schott-Hildebrand, Sabine, Herth, Felix J, Schneider, Marc A, Meister, Michael, Muley, Thomas R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521486/ https://www.ncbi.nlm.nih.gov/pubmed/26236175 http://dx.doi.org/10.1186/s12014-015-9093-6 |
Ejemplares similares
-
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma
por: Schneider, Marc A., et al.
Publicado: (2016) -
Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC
por: Schneider, Marc A., et al.
Publicado: (2018) -
Pathways regulating the expression of the immunomodulatory protein glycodelin in non-small cell lung cancer
por: Weber, Rebecca, et al.
Publicado: (2018) -
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019) -
AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients
por: Schneider, Marc A., et al.
Publicado: (2017)